Target intelligence / Profile preview

Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 3 (EIF2S2P3)

Target
EIF2S2P3
Molecular classification
Other (Pseudogene)
01

Overview

EIF2S2P3 is a human pseudogene located on chromosome 10 (NCBI Gene: 283014), annotated as "Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 3." Pseudogenes like EIF2S2P3 do not encode functional proteins and do not serve verified biological roles or act as drug targets. No disease associations, therapeutic targeting, or roles as biomarkers or safety concerns have been established. Its annotation exists primarily for genomic completeness and may help in distinguishing true functional homologs. Clarification of potential confusion: The functional gene EIF2S2, encoding the beta subunit of eukaryotic translation initiation factor 2, is a well-studied protein involved in translation initiation and is investigated for possible roles in cancer biology and as a prognostic biomarker. EIF2S2P3 is a pseudogene version and does not fulfill any of these roles, nor is it a direct target of drugs or biological regulation. Some resources list multiple similarly named pseudogenes (such as EIF2S2P2), which are equally non-functional. If therapeutic, biological, or biomarker data are required, please refer to the main protein-coding gene EIF2S2 rather than this pseudogene.

Other names
Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa pseudogene 3Eukaryotic translation initiation factor 2, subunit 2 beta pseudogene 3Eukaryotic initiation factor 2-beta pseudogene 3

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 3 (EIF2S2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 3 (EIF2S2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call